| Literature DB >> 25151564 |
Jennifer A Johnson1, Paul E Sax2.
Abstract
In this article, we review the options for initial antiretroviral therapy, including the data from clinical trials to support these choices and the factors to consider in selection of a regimen to best fit each patient.Entities:
Keywords: Antiretroviral therapy (ART); HIV; Integrase strand transfer inhibitor (INSTI); Nonnucleoside reverse transcriptase inhibitor (NNRTI); Nucleoside/nucleotide reverse transcriptase inhibitor (NRTI); Protease inhibitor (PI); Treatment-naïve
Mesh：
Substances：
Year: 2014 PMID： 25151564 DOI： 10.1016/j.idc.2014.06.003
Source DB: PubMed Journal: Infect Dis Clin North Am ISSN： 0891-5520 Impact factor: 5.982